490 related articles for article (PubMed ID: 28655421)
1. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
2. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.
Niu Y; Zhu H; Liu J; Fan H; Sun L; Lu W; Liu X; Li L
Chem Biol Interact; 2011 Feb; 189(3):161-6. PubMed ID: 21167141
[TBL] [Abstract][Full Text] [Related]
3. Identification of the biologically active constituents of Camellia japonica leaf and anti-hyperuricemic effect in vitro and in vivo.
Yoon IS; Park DH; Kim JE; Yoo JC; Bae MS; Oh DS; Shim JH; Choi CY; An KW; Kim EI; Kim GY; Cho SS
Int J Mol Med; 2017 Jun; 39(6):1613-1620. PubMed ID: 28487949
[TBL] [Abstract][Full Text] [Related]
4. Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction.
Yang C; Liu Y; Tu Y; Li L; Du J; Yu D; He P; Wang T; Liu Y; Chen H; Li Y
Bioorg Chem; 2023 Feb; 131():106320. PubMed ID: 36527991
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
6.
Mehmood A; Rehman AU; Ishaq M; Zhao L; Li J; Usman M; Zhao L; Rehman A; Zad OD; Wang C
Comb Chem High Throughput Screen; 2020; 23(9):917-930. PubMed ID: 32342806
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C.
Tang HJ; Zhang XW; Yang L; Li W; Li JH; Wang JX; Chen J
Eur J Med Chem; 2016 Nov; 124():637-648. PubMed ID: 27614410
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J
Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH
Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987
[TBL] [Abstract][Full Text] [Related]
11. Effects of extracts from Corylopsis coreana Uyeki (Hamamelidaceae) flos on xanthine oxidase activity and hyperuricemia.
Yoon IS; Park DH; Ki SH; Cho SS
J Pharm Pharmacol; 2016 Dec; 68(12):1597-1603. PubMed ID: 27696407
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives as novel xanthine oxidase inhibitors.
Zhang TJ; Zhang Y; Zhang ZH; Wang ZR; Zhang X; Hu SS; Lu PF; Guo S; Meng FH
Bioorg Med Chem Lett; 2022 Mar; 60():128582. PubMed ID: 35077850
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
Hofmann E; Webster J; Do T; Kline R; Snider L; Hauser Q; Higginbottom G; Campbell A; Ma L; Paula S
Bioorg Med Chem; 2016 Feb; 24(4):578-87. PubMed ID: 26762836
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design and biological evaluation of novel 2-(indol-2-yl) thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Jang JW; Kim TH; Park H; Park WS; Jung SH; Kim GT
Bioorg Med Chem Lett; 2016 Feb; 26(3):950-954. PubMed ID: 26774578
[TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of pyrimidones and evaluation of their xanthine oxidase inhibitory and antioxidant activities.
Gurupadaswamy HD; Girish V; Zameer F; Hegdekatte R; Chauhan JB; Khanum SA
Arch Pharm (Weinheim); 2013 Nov; 346(11):805-11. PubMed ID: 24114987
[TBL] [Abstract][Full Text] [Related]
18. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
[TBL] [Abstract][Full Text] [Related]
19. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
20. Effects of lobetyolin on xanthine oxidase activity
Yoon IS; Cho SS
Nat Prod Res; 2021 May; 35(10):1667-1670. PubMed ID: 31140315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
